Testing lung cancer drugs on your fluid sample
Part of Cancer, Lungs & breathing clinical trials.
This study collects fluid that builds up around your lungs (pleural effusion) during a drainage procedure you already need. Researchers test how different drugs affect your cancer cells in the lab to help predict which treatments might work best for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have lung cancer or suspected lung cancer confirmed by CT scan
- You have fluid buildup around your lungs causing shortness of breath
- You need to have this fluid drained for medical reasons anyway
- You're willing to donate some of that fluid for drug testing
- You can understand the study and agree in writing to participate
- You have not had negative (cancer-free) test results on lung fluid in the past 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug given directly into the chest cavity to treat fluid buildup caused by non-small cell lung cancer. It may help ease breathing problems and control the fluid.
This trial tests a new drug called JMKX000197 against a standard chemotherapy drug (cisplatin) to see which is better at reducing fluid buildup around the lungs in people with advanced cancer. The goal is to ease breathing and improve quality of life.
This study is looking at certain substances in the fluid around the lungs (pleural effusion) of people with lung adenocarcinoma. It may help doctors understand this condition better and find new ways to treat it.
This study tests whether a thin, flexible tube (like a small camera) can safely and effectively help doctors get tissue samples from fluid around the lung. It compares a single-use flexible tool to a standard semi-rigid scope, and may help find the cause of your lung fluid.
This study looks at two ways to manage a buildup of fluid around the lung caused by cancer. One method uses a temporary tube to drain the fluid, and the other uses a procedure to seal the space so fluid does not come back. The goal is to see which approach helps people breathe more easily and feel better.
This trial tests an investigational drug called JMKX000197 given into the chest to control fluid buildup caused by cancer. It is for people with advanced solid tumors that have led to a moderate or large pleural effusion requiring drainage.
Hear when a new Lung Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.